MedXL completed the acquisition of Liebel-Flarsheim Canada from Guerbet for $12m.

MedXL, a specialist in medical devices and sterile pre-filled syringes, completed the acquisition of Liebel-Flarsheim Canada, a pharmaceutical site, from Guerbet, a France-based manufacturer of contrast agents used in medical imaging, for $12m. “Guerbet is delighted with this agreement with MedXL, a partner committed to sustainable growth that has chosen to invest in an efficient industrial site and high-quality team. Thanks to this sale we can optimize capacity utilization at our three pharmaceutical sites, which produce products for Guerbet alone. This will help us to continuously improve our competitiveness and give us the means to accelerate our growth,” Jean-François Blanc, Guerbet Vice President of Technical Operations.